Tumour model

MCF7

Duct adenocarcinoma
XenograftIn vitro

MCF7 cells

Human MCF7 cells were isolated from the pleural effusion of a patient with metastatic breast cancer.

Tumour growth in vivo

Subcutaneous implantation of an oestrogen pellet (0.18mg of B-oestradiol) in the left flank and the following day, the cells were collected from a tissue culture flask and injected subcutaneously in the right flank of SCID/CB17 mice. The resulting tumours were monitored by measuring two diameters with calipers, and extrapolating the volume to a sphere.

The mice bearing MCF7 tumours can be treated by intra-peritoneal, intra-venous, intra-tumoral or subcutaneous injection of the compounds. Per os administration is also possible.

Figure 1: (View PDF)
Tumour growth curve of the MCF7 cells as subcutaneous tumours. Mean ± SEM

Download PDF

Model characteristics

Organism
Human
Tissue of origin
Breast
Pathology
Duct adenocarcinoma
Model type
In vitro, Xenograft
Availability
Off the shelf (time of expansion)

Request this model

Tell us about your compound and your endpoints. Our team confirms feasibility, timelines and study design before any commitment.

Related models

Other models sharing the same tissue of origin.

Model
Organism
Tissue of origin
Pathology
Type
Mouse
Breast
Breast cancer
SyngeneicIn vitro
Human
Breast
Ductal adenocarcinoma
XenograftIn vitroResistant
Mouse
Breast
From SCID
SyngeneicIn vitro
Mouse
Breast
Carcinoma
SyngeneicIn vitro
Mouse
Breast
Adenocarcinoma
SyngeneicIn vitro
Human
Breast
Invasive breast carcinoma
XenograftIn vitro